We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $66.6B Turnover 22.96%
1-Year Est. Return 7.35%
This Fund
S&P 500
This Quarter Est. Return
-9.26%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$33.1B
AUM Growth
-$3.78B
Cap. Flow
+$637M
Cap. Flow %
1.92%
Top 10 Hldgs %
41.49%
Holding
362
New
35
Increased
114
Reduced
147
Closed
36
Avg Time Held
5.1 years
Top 10 Avg Time Held
5.4 years
Top 20 Avg Time Held
6.8 years

Top Buys

Rank Stock Value
1
SHOP icon
Shopify
SHOP
+$319M
2
IT icon
Gartner
IT
+$314M
3
VRSK icon
Verisk Analytics
VRSK
+$245M
4
GWRE icon
Guidewire Software
GWRE
+$221M
5
FDS icon
Factset
FDS
+$203M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.6%
2 Financials 21.27%
3 Technology 17.34%
4 Industrials 8.63%
5 Healthcare 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SEI icon
276
Solaris Energy Infrastructure
SEI
$4.14B
$2.2M 0.01%
+38,970
New +$2.11M
2026 Q1
0 quarters
PLTR icon
277
Palantir
PLTR
$447B
$1.9M 0.01%
+13,005
New +$1.99M
2026 Q1
0 quarters
TERN icon
278
DELISTED
Terns Pharmaceuticals
TERN
$1.85M 0.01%
+35,000
New +$1.44M
2026 Q1
0 quarters
SYK icon
279
Stryker
SYK
$113B
$1.81M 0.01%
5,500
-2,500
-31% -$898K
2023 Q4
9 quarters
SNPS icon
280
Synopsys
SNPS
$86.9B
$1.77M 0.01%
4,473
-18,782
-81% -$8.49M
2025 Q3
2 quarters
ABBV icon
281
AbbVie
ABBV
$504B
$1.74M 0.01%
8,000
-16,800
-68% -$3.73M
2025 Q3
2 quarters
KYMR icon
282
Kymera Therapeutics
KYMR
$8.69B
$1.67M 0.01%
20,000
– –
2025 Q3
2 quarters
PTGX icon
283
Protagonist Therapeutics
PTGX
$8.34B
$1.58M ﹤0.01%
15,000
+6,700
+81% +$593K
2025 Q4
1 quarter
HDB icon
284
HDFC Bank
HDB
$122B
$1.57M ﹤0.01%
63,292
-48,579
-43% -$1.51M
2021 Q4
17 quarters
CYTK icon
285
Cytokinetics
CYTK
$8.61B
$1.52M ﹤0.01%
+23,000
New +$1.46M
2026 Q1
0 quarters
MS icon
286
Morgan Stanley
MS
$284B
$1.5M ﹤0.01%
9,100
+2,500
+38% +$433K
2025 Q4
1 quarter
XENE icon
287
Xenon Pharmaceuticals
XENE
$3.25B
$1.45M ﹤0.01%
25,000
-5,000
-17% -$230K
2021 Q4
17 quarters
BAC icon
288
Bank of America
BAC
$359B
$1.37M ﹤0.01%
+28,200
New +$1.46M
2026 Q1
0 quarters
ASND icon
289
Ascendis Pharma A/S
ASND
$14.8B
$1.28M ﹤0.01%
5,600
– –
2025 Q3
2 quarters
APGE icon
290
DELISTED
Apogee Therapeutics
APGE
$1.26M ﹤0.01%
+15,000
New +$1.09M
2026 Q1
0 quarters
DEI icon
291
Douglas Emmett
DEI
$1.63B
$1.17M ﹤0.01%
124,363
– –
2013 Q2
51 quarters
MU icon
292
Micron Technology
MU
$996B
$1.13M ﹤0.01%
3,347
-3,004
-47% -$1.18M
2025 Q4
1 quarter
COF icon
293
Capital One
COF
$124B
$1.09M ﹤0.01%
6,000
-135
-2% -$28.2K
2025 Q3
2 quarters
BLK icon
294
Blackrock
BLK
$175B
$1.07M ﹤0.01%
1,110
+58
+6% +$61K
2018 Q1
32 quarters
ODD icon
295
ODDITY Tech
ODD
$1.03B
$838K ﹤0.01%
62,630
-1,291,085
-95% -$32.4M
2023 Q3
10 quarters
JKHY icon
296
Jack Henry & Associates
JKHY
$10.7B
$793K ﹤0.01%
5,016
-94
-2% -$16.1K
2020 Q1
24 quarters
BRK.A icon
297
Berkshire Hathaway Class A
BRK.A
$1.14T
$718K ﹤0.01%
1
– –
2016 Q3
38 quarters
PGR icon
298
Progressive
PGR
$127B
$684K ﹤0.01%
3,452
-128
-4% -$26.4K
2022 Q2
15 quarters
GS icon
299
Goldman Sachs
GS
$256B
$677K ﹤0.01%
800
– –
2016 Q3
38 quarters
LSCC icon
300
Lattice Semiconductor
LSCC
$14.7B
$676K ﹤0.01%
7,292
+3,465
+91% +$311K
2025 Q4
1 quarter

Similar funds

BAMCO Inc's Q1 2026 Portfolio in Review

As of Q1 2026, BAMCO Inc held 362 positions worth $33.1B, down 10% from $36.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

BAMCO Inc's Q1 2026 filing shows 35 new, 114 increased, 147 reduced and 36 closed positions. Its largest new stake was Forgent Power Solutions: 4,674,583 shares worth $137M. The largest sale was Clearwater Analytics, an estimated $181M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Financials and Technology.

  • BAMCO Inc's largest Q1 2026 buy was Forgent Power Solutions: 4,674,583 shares worth $137M.
  • BAMCO Inc added most to Shopify in Q1 2026, an estimated $319M increase.
  • BAMCO Inc's biggest Q1 2026 reduction was Clearwater Analytics, cutting an estimated $181M.
  • BAMCO Inc fully exited Exact Sciences in Q1 2026, selling an estimated $96.9M.
  • BAMCO Inc's ten largest holdings make up 41% of its $33.1B portfolio in Q1 2026.
  • BAMCO Inc opened 35 new positions and closed 36 in Q1 2026.
  • BAMCO Inc's portfolio value fell 10% quarter-over-quarter to $33.1B.

Based on BAMCO Inc's 13F filing for Q1 2026, filed 15 May 2026.